Ascentage Pharma Group International
Ascentage Pharma Group International (AAPG) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
aapg · stock forecast · 1 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 1 Wall Street analysts in the past 3 months
Buy
1 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$40.00
Consensus
$40.00
+130.9% upside
Low
$40.00
Median: $40 · Last Close: $17.32
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $16.46 | ↓ 5.00% |
1-day model range: $16.33–$16.58. Peak: $16.58 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $15 | -15.6% |
| 2028 | $13 | -22.9% |
| 2029 | $13 | -26.5% |
| 2030 | $12 | -28.4% |
| 2031 | — | -29.5% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AAPG · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-13 | BTIG | Maintains | Buy→Buy |
| 2026-03-26 | BTIG | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Ascentage Pharma Group International (AAPG) stock. Of the recent 2 rating actions, 0 were upgrades and 0 were downgrades. 1 analysts currently cover AAPG.
Analyst Recommendation Trends
AAPG analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$949M
↓ 62.0% YoY
Revenue Next Year
$1.6B
↑ 67.5% YoY
EPS This Year
$-7.46
EPS Next Year
$-2.91
↓ 60.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast AAPG EPS of $-7.46 for the current fiscal year, based on estimates from 4 analysts. The AAPG revenue forecast is $949M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The AAPG stock forecast is supported by two independent data sources: analyst consensus ratings from 1 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AAPG price target is $40.00 (+130.9% upside), with an analyst consensus of Buy.
The AAPG short-term stock prediction for tomorrow is $16.46 (-5.00%). The AAPG stock price prediction for 2027 estimates an average of $15. The AAPG stock prediction for 2030 projects a range of $12–$13.
Ascentage Pharma Group International trades on NASDAQ under the ticker AAPG. The AAPG stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
AAPG forecast · 8 questionsAccording to 1 Wall Street analysts, the average 12-month AAPG price target is $40.00, with a high forecast of $40.00 and a low of $40.00. The median price target is shown in the chart above when available. This implies +130.9% potential upside from the current price of $17.32.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.